Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B9df1e16455661098bf3b86eb60376de6> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B9df1e16455661098bf3b86eb60376de6 NCIT_P378 "NCI" @default.
- B9df1e16455661098bf3b86eb60376de6 type Axiom @default.
- B9df1e16455661098bf3b86eb60376de6 annotatedProperty IAO_0000115 @default.
- B9df1e16455661098bf3b86eb60376de6 annotatedSource NCIT_C78478 @default.
- B9df1e16455661098bf3b86eb60376de6 annotatedTarget "A cancer vaccine consisting of a recombinant form of human melanoma antigen A3 (MAGE-A3) combined with a proprietary adjuvant with potential immunostimulatory and antineoplastic activities. Upon administration, astuprotimut-R may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing the MAGE-A3 antigen, resulting in tumor cell death. MAGE-A3, a tumor-associated antigen (TAA) originally discovered in melanoma cells, is expressed by various tumor types. The proprietary immunostimulating adjuvant in this agent is composed of a specific combination of immunostimulating compounds selected to increase the anti-tumor immune response to MAGE-A3." @default.